Global Infertility Drugs Market: Online Retailing to be a Key Trend till 2022


Published on : Apr 04, 2018

Albany, New York, April 4, 2018: Various diseases such as high blood pressure, obesity, and diabetes, resulting from sedentary lifestyle of people, have been associated with infertility. Women suffering from diabetes face challenges in conceiving owing to high glucose level, which prevents implantation of embryo in the uterus. This further results into pregnancy complications or even miscarriage. This possible effect of a lethargic lifestyle of humans, infertility has adverse effects on their health, which in turn has driven demand for drugs that combat infertility issues. A new report, titled “Drugs for Infertility: Global Markets to 2022”, has been recently added to the comprehensive repository of Market Research Hub (MRH). The report projects a robust growth for the market, primarily driven by growing prevalence of lifestyle diseases, and rising awareness in coupled regarding infertility.

Online Retailing – A Key Trend

The report states growth in online retail sales of infertility drugs to be a key trend gaining momentum over the past few years. With the advent of the internet, affected patients and drug suppliers are offered with the convenience in purchasing and selling products in short duration, compared to walking to stores. It has also saved the embarrassment for relatively conservative communities. Online retailing is gradually becoming a popular distribution channel for drugs apropos to sexual disorders.

Availability of wider range of products, highly competitive prices, and quick delivery services are key growth determinants for online retailing. Growing traction of ecommerce, and aims of therapeutic drug vendors to tap opportunities in infertility medications are likely to drive growth of the infertility drugs market worldwide in the near future. In contrast, inclination of infertile patients toward modes of treatment other than drugs will continue to restrain the market growth. Infertile people currently tend to opt for other modes of treatment such as the assisted reproductive technology (ART), with in-vitro fertilization (IVF) being the most prevalent.

Increasing Awareness about Infertility in Couples

The report further states that surging awareness on sex-related diseases, such as fertility issues, around the world has been significantly rubbing off on demand from the infertility treatment industry. Different government and private organizations across the globe have been taking efforts to encourage couples who face such issues to come forth and seek professional assistance in order to combat the problem.

For instance, National Fertility Awareness Week celebrated in the U.K. from 30th Oct – 5th November, 2017, helped in spreading awareness, providing support, raising funds, and changing perspective of the general public toward infertility. Such awareness campaigns, dedicated toward creating a positive influence on the demographic regarding infertility treatment, are expected to drive demand for infertility drugs.

For women, controlled ovarian hyperstimulation (COH) has become an integral part of infertility treatments, as developing single follicle with good egg or multiple follicles enhances pregnancy rates. Numerous drugs for infertility treatment are available in the market, which include corticosteroids, Bromocriptine (Parlodel), Progesterone, Gonadotropins with GnRH agonists, and Clomiphene Citrate (Clomid). Although few studies associated increased risk of ovarian cancer trailing consumption of clomiphene citrate and possibly gonadotropins, definite conclusions await evaluation of large ongoing analyses.

 

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top